TP53-mutant myelodysplastic syndrome and acute myeloid leukemia: the black hole of hematology

Blood Adv. 2022 Mar 22;6(6):1917-1918. doi: 10.1182/bloodadvances.2021006580.
No abstract available

Publication types

  • Comment

MeSH terms

  • Hematology*
  • Humans
  • Leukemia, Myeloid, Acute* / diagnosis
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / genetics
  • Myelodysplastic Syndromes* / diagnosis
  • Prognosis
  • Tumor Suppressor Protein p53 / genetics

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53